Martine Rothblatt, United Therapeutics CEO (AP Photo/Jack Plunkett)
September 20, 2022 09:52 AM EDT
R&D
Pharma

Long af­ter first nod for in­haled Ty­va­so, Unit­ed Ther­a­peu­tics scraps PhI­II in PH with COPD

Kyle LaHucik

Senior Reporter

Af­ter a re­cent court win for its in­haled pul­monary ar­te­r­i­al hy­per­ten­sion drug, push­ing off com­pe­ti­tion for a few more years, Unit­ed Ther­a­peu­tics has qui­et­ly …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Trump names Johns Hop­kins re­searcher Mar­ty Makary to lead the FDA; al­so names CDC, Sur­geon Gen­er­al picks

FDA ap­proves Bridge­Bio's heart dis­ease drug, set­ting up com­pe­ti­tion with Pfiz­er, Al­ny­lam

FDA vac­cine chief Pe­ter Marks pledges to stay as long as he's wel­come

Drug or bi­o­log­ic? An Eli Lil­ly law­suit could im­pact weight loss drug com­pounders

Pa­tient dies in Neu­ro­gene's Rett syn­drome study

sponsored

Are pro­grams with com­pound­ed GLP-1s safe for your pop­u­la­tion?

A service from the Financial Times